Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Thomas, Rutherford"'
Autor:
Yi Zhang, Roslyn Tedja, Michael Millman, Terrence Wong, Alexandra Fox, Hussein Chehade, Meyer Gershater, Nicholas Adzibolosu, Radhika Gogoi, Matthew Anderson, Thomas Rutherford, Zhenggang Zhang, Michael Chopp, Gil Mor, Ayesha B. Alvero
Publikováno v:
Journal of Ovarian Research, Vol 16, Iss 1, Pp 1-12 (2023)
Abstract Background Chromobox protein homolog 7 (CBX7), a member of the Polycomb repressor complex, is a potent epigenetic regulator and gene silencer. Our group has previously reported that CBX7 functions as a tumor suppressor in ovarian cancer cell
Externí odkaz:
https://doaj.org/article/f5ada7a46fcc49dba4a2615fa34a89ec
Autor:
Nicholas Adzibolosu, Ayesha B. Alvero, Rouba Ali-Fehmi, Radhika Gogoi, Logan Corey, Roslyn Tedja, Hussein Chehade, Vir Gogoi, Robert Morris, Matthew Anderson, Julie Vitko, Clarissa Lam, Douglas B. Craig, Sorin Draghici, Thomas Rutherford, Gil Mor
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionOvarian cancer recurs in most High Grade Serous Ovarian Cancer (HGSOC) patients, including initial responders, after standard of care. To improve patient survival, we need to identify and understand the factors contributing to early or la
Externí odkaz:
https://doaj.org/article/262a995315a3479982fcdcf6edad0ecd
Autor:
Gil Mor, Peter E. Schwartz, Thomas Rutherford, Masoud Azori, Herbert Yu, Ruben Flores-Saaib, Aliza Leiser, Jeannette Tenthorey, Yinglei Lai, Ayesha B. Alvero, David C. Ward, Gary Longton, Ziding Feng, Irene Visintin
{Supplementary Data} from Diagnostic Markers for Early Detection of Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0805f3529e281003dab0895ca9649073
https://doi.org/10.1158/1078-0432.22439605.v1
https://doi.org/10.1158/1078-0432.22439605.v1
Autor:
Karen H. Lu, Dianne M. Finkelstein, David Alberts, Susan Nayfield, Carol H. Kasten, Nora K. Horick, Lori Minasian, William Welch, Patrick M. Sluss, Joan Walker, Carol J. Fabian, Ira Horowitz, Deborah Armstrong, Kelly-Anne Phillips, Katie Wakeley, Steven A. Elg, Robert Edwards, Susan A. Davidson, Susan Domchek, Andrew Berchuck, Claudine Isaacs, Charles W. Drescher, John Boggess, Edward Partridge, David M. O'Malley, Wendy R. Brewster, Thomas Rutherford, Mary B. Daly, Mark Sherman, John O. Schorge, Gustavo Rodriguez, Marion Piedmonte, Powel Brown, Phuong L. Mai, Saundra S. Buys, Mark H. Greene, Steven J. Skates
Purpose: Women at familial/genetic ovarian cancer risk often undergo screening despite unproven efficacy. Research suggests each woman has her own CA125 baseline; significant increases above this level may identify cancers earlier than standard 6- to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::148a42b539ebb55914256e2dc085e721
https://doi.org/10.1158/1078-0432.c.6526178.v1
https://doi.org/10.1158/1078-0432.c.6526178.v1
Autor:
Gil Mor, Peter E. Schwartz, Thomas Rutherford, Masoud Azori, Herbert Yu, Ruben Flores-Saaib, Aliza Leiser, Jeannette Tenthorey, Yinglei Lai, Ayesha B. Alvero, David C. Ward, Gary Longton, Ziding Feng, Irene Visintin
Purpose: Early detection would significantly decrease the mortality rate of ovarian cancer. In this study, we characterize and validate the combination of six serum biomarkers that discriminate between disease-free and ovarian cancer patients with hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a47deb57c0f5e9b1aef1e69ea695931
https://doi.org/10.1158/1078-0432.c.6517045.v1
https://doi.org/10.1158/1078-0432.c.6517045.v1
Autor:
Gil Mor, Peter E. Schwartz, Thomas Rutherford, Masoud Azori, Herbert Yu, Ruben Flores-Saaib, Aliza Leiser, Jeannette Tenthorey, Yinglei Lai, Ayesha B. Alvero, David C. Ward, Gary Longton, Ziding Feng, Irene Visintin
Correction: Clin Cancer Res 2008 14: 1065-1072 from Diagnostic Markers for Early Detection of Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::103163a2a26fe77132e9fc10df00d651
https://doi.org/10.1158/1078-0432.22439608
https://doi.org/10.1158/1078-0432.22439608
Autor:
Karen H. Lu, Dianne M. Finkelstein, David Alberts, Susan Nayfield, Carol H. Kasten, Nora K. Horick, Lori Minasian, William Welch, Patrick M. Sluss, Joan Walker, Carol J. Fabian, Ira Horowitz, Deborah Armstrong, Kelly-Anne Phillips, Katie Wakeley, Steven A. Elg, Robert Edwards, Susan A. Davidson, Susan Domchek, Andrew Berchuck, Claudine Isaacs, Charles W. Drescher, John Boggess, Edward Partridge, David M. O'Malley, Wendy R. Brewster, Thomas Rutherford, Mary B. Daly, Mark Sherman, John O. Schorge, Gustavo Rodriguez, Marion Piedmonte, Powel Brown, Phuong L. Mai, Saundra S. Buys, Mark H. Greene, Steven J. Skates
Supplementary Materials describing "Inclusion and Exclusion Criteria" for the two studies, a detailed description of the "ROCA methods", "Sample Handling and CA125 Assay Instrumentation", and derivation of standards for "Specificity and Positive Pred
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::262c67523a33813af5b9348d6781e13d
https://doi.org/10.1158/1078-0432.22465889
https://doi.org/10.1158/1078-0432.22465889
Supplementary Figure 2 from A KRAS-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk
Autor:
Joanne B. Weidhaas, Frank J. Slack, Daniel Zelterman, Ellen Matloff, Alessandro Santin, Peter Schwartz, Thomas Rutherford, Harvey Risch, Herbert Yu, Andrew K. Godwin, Pei Hui, Trupti Paranjape, Renata Tassi, Rachel Blitzblau, Cory Pelletier, Lena J. Chin, Sunitha Nallur, Rachel Barnett, Marta Boeke, Lingeng Lu, Elena Ratner
Supplementary Figure 2 from A KRAS-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e685b41ea8034736e053cb60e53b59c
https://doi.org/10.1158/0008-5472.22383336.v1
https://doi.org/10.1158/0008-5472.22383336.v1
Autor:
Joanne B. Weidhaas, Frank J. Slack, Daniel Zelterman, Ellen Matloff, Alessandro Santin, Peter Schwartz, Thomas Rutherford, Harvey Risch, Herbert Yu, Andrew K. Godwin, Pei Hui, Trupti Paranjape, Renata Tassi, Rachel Blitzblau, Cory Pelletier, Lena J. Chin, Sunitha Nallur, Rachel Barnett, Marta Boeke, Lingeng Lu, Elena Ratner
Supplementary Table 1 from A KRAS-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3675ce7b040bdfbb536145d35417b4ee
https://doi.org/10.1158/0008-5472.22383333.v1
https://doi.org/10.1158/0008-5472.22383333.v1
Autor:
Joanne B. Weidhaas, Frank J. Slack, Daniel Zelterman, Ellen Matloff, Alessandro Santin, Peter Schwartz, Thomas Rutherford, Harvey Risch, Herbert Yu, Andrew K. Godwin, Pei Hui, Trupti Paranjape, Renata Tassi, Rachel Blitzblau, Cory Pelletier, Lena J. Chin, Sunitha Nallur, Rachel Barnett, Marta Boeke, Lingeng Lu, Elena Ratner
Ovarian cancer (OC) is the single most deadly form of women's cancer, typically presenting as an advanced disease at diagnosis in part due to a lack of known risk factors or genetic markers of risk. The KRAS oncogene and altered levels of the microRN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::289e4764c2ad57c4d4545a124613ed89
https://doi.org/10.1158/0008-5472.c.6500502
https://doi.org/10.1158/0008-5472.c.6500502